Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


QUOTED. 7 February 2020. Annemien Pullen.

Executive Summary

Veeva Systems, the developer of a suite of applications designed for life sciences companies, sees the forthcoming EU Medical Device Regulation (MDR) as an opportunity to strengthen its links with the medtech industry. See what Veeva’s Annemien Pullen said about it here.

"MDR is an opportunity for industry to start with a clean slate. I think EU MDR is shaking the industry up and launching it into the 21st century with regard to business operations. The transition periods are very short. So the debate in the industry on how to reach compliance given the tight timeframe is very legitimate. Because many device manufacturers have grown through acquisitions and they have,  in some cases, decades of legacy documents, processes and systems that they have to remediate, transition and catapult into the 21st century." – Annemien Pullen, director of European medical devices and diagnostics strategy, Veeva Systems

Click here for a free trial of Medtech Insight


Related Content





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts